Literature DB >> 27022757

Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique.

Kazuhide Sato1, Peter L Choyke1, Kobayashi Hisataka2.   

Abstract

Recent developments in tissue engineering offer innovative solutions for many diseases. For example, tissue engineering using induced pluripotent stem cell (iPS) emerged as a new method in regenerative medicine. Although this tissue regeneration is promising, contamination with unwanted cells during tissue cultures is a major concern. Moreover, there is a safety concern regarding tumorigenicity after transplantation. Therefore, there is an urgent need for eliminating specific cells without damaging other cells that need to be protected, especially in established tissue. Here, we present a method for specific cell elimination from a mixed 3D cell culture in vitro with near infrared photoimmunotherapy (NIR-PIT) without damaging non-targeted cells. This technique enables the elimination of specific cells from mixed cell cultures or tissues.

Mesh:

Year:  2016        PMID: 27022757      PMCID: PMC4828982          DOI: 10.3791/53633

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  26 in total

Review 1.  Derive and conquer: sourcing and differentiating stem cells for therapeutic applications.

Authors:  Irina Klimanskaya; Nadia Rosenthal; Robert Lanza
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

2.  Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.

Authors:  Kazuhide Sato; Rira Watanabe; Hirofumi Hanaoka; Toshiko Harada; Takahito Nakajima; Insook Kim; Chang H Paik; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Oncol       Date:  2014-01-22       Impact factor: 6.603

3.  Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging.

Authors:  Takahito Nakajima; Kohei Sano; Makoto Mitsunaga; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Res       Date:  2012-07-16       Impact factor: 12.701

4.  Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer.

Authors:  Kazuhide Sato; Hirofumi Hanaoka; Rira Watanabe; Takahito Nakajima; Peter L Choyke; Hisataka Kobayashi
Journal:  Mol Cancer Ther       Date:  2014-11-21       Impact factor: 6.261

5.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

6.  Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.

Authors:  Naoto Shirasu; Hiromi Yamada; Hirotomo Shibaguchi; Motomu Kuroki; Masahide Kuroki
Journal:  Int J Cancer       Date:  2014-04-25       Impact factor: 7.396

7.  Tissue engineering's green shoots of disruptive innovation.

Authors:  Martin A Birchall; Alexander M Seifalian
Journal:  Lancet       Date:  2014-04-10       Impact factor: 79.321

8.  Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.

Authors:  Makoto Mitsunaga; Takahito Nakajima; Kohei Sano; Gabriela Kramer-Marek; Peter L Choyke; Hisataka Kobayashi
Journal:  BMC Cancer       Date:  2012-08-08       Impact factor: 4.430

9.  Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model.

Authors:  Kazuhide Sato; Tadanobu Nagaya; Yuko Nakamura; Toshiko Harada; Peter L Choyke; Hisataka Kobayashi
Journal:  Oncotarget       Date:  2015-08-14

10.  Improving the efficacy of Photoimmunotherapy (PIT) using a cocktail of antibody conjugates in a multiple antigen tumor model.

Authors:  Takahito Nakajima; Kohei Sano; Peter L Choyke; Hisataka Kobayashi
Journal:  Theranostics       Date:  2013-04-23       Impact factor: 11.556

View more
  7 in total

Review 1.  Near-Infrared Photoimmunotherapy for Cancers of the Gastrointestinal Tract.

Authors:  Tadanobu Nagaya; Peter L Choyke; Hisataka Kobayashi
Journal:  Digestion       Date:  2020-12-14       Impact factor: 3.672

2.  Near-Infrared Photoimmunotherapy of Cancer.

Authors:  Hisataka Kobayashi; Peter L Choyke
Journal:  Acc Chem Res       Date:  2019-07-23       Impact factor: 22.384

3.  Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin.

Authors:  Yuko Nishinaga; Kazuhide Sato; Hirotoshi Yasui; Shunichi Taki; Kazuomi Takahashi; Misae Shimizu; Rena Endo; Chiaki Koike; Noriko Kuramoto; Shota Nakamura; Takayuki Fukui; Hiroshi Yukawa; Yoshinobu Baba; Mika K Kaneko; Toyofumi F Chen-Yoshikawa; Hisataka Kobayashi; Yukinari Kato; Yoshinori Hasegawa
Journal:  Cells       Date:  2020-04-20       Impact factor: 6.600

4.  Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.

Authors:  Yoshitaka Isobe; Kazuhide Sato; Yuko Nishinaga; Kazuomi Takahashi; Shunichi Taki; Hirotoshi Yasui; Misae Shimizu; Rena Endo; Chiaki Koike; Noriko Kuramoto; Hiroshi Yukawa; Shota Nakamura; Takayuki Fukui; Koji Kawaguchi; Toyofumi F Chen-Yoshikawa; Yoshinobu Baba; Yoshinori Hasegawa
Journal:  EBioMedicine       Date:  2020-01-23       Impact factor: 8.143

5.  Near-infrared-induced drug release from antibody-drug double conjugates exerts a cytotoxic photo-bystander effect.

Authors:  Kazuomi Takahashi; Hirotoshi Yasui; Shunichi Taki; Misae Shimizu; Chiaki Koike; Kentaro Taki; Hiroshi Yukawa; Yoshinobu Baba; Hisataka Kobayashi; Kazuhide Sato
Journal:  Bioeng Transl Med       Date:  2022-08-21

6.  Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity.

Authors:  Shunichi Taki; Kazuhide Sato; Kohei Matsuoka; Yuko Nishinaga; Kazuomi Takahashi; Hirotoshi Yasui; Chiaki Koike; Misae Shimizu; Mitsuo Sato
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 12.469

7.  HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer.

Authors:  Kazuomi Takahashi; Shunichi Taki; Hirotoshi Yasui; Yuko Nishinaga; Yoshitaka Isobe; Toshinori Matsui; Misae Shimizu; Chiaki Koike; Kazuhide Sato
Journal:  Cancer Med       Date:  2021-11-02       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.